Johnson & Johnson Surpasses Earnings Forecasts Driven by Cancer Drug Sales
Quick Summary The article highlights Johnson & Johnson’s (J&J) financial earnings, noting that the company beat estimates due to strong sales from its cancer drug portfolio. It does not provide